Luigi Naldini

38PUBLICATIONS
214CO-AUTHORS
Immunogenetics (incl. genetic immunology)Epigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jun 01, 2026
Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial.

|Jun 01, 2026
Selection of human hematopoietic stem cells bearing the intended functional edit by transient AND-gate reporters.

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|Jul 02, 2025
A cross-talk established by tumor-targeted cytokines rescues CAR T cell activity and engages host T cells against glioblastoma in mice.

Federico Rossari, Giorgia Alvisi, Melania Cusimano

|May 28, 2025
In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking.

Michela Milani, Anna Fabiano, Marta Perez-Rodriguez

|Apr 16, 2025
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs.

Mohsen Hosseini, Veronique Voisin, Ali Chegini

Pageof 7

Frequent Collaborators

12 joint publications

Alessandro Aiuti

10 joint publications

Samuele Ferrari

8 joint publications

Bernhard Gentner

7 joint publications

Alessio Cantore